Tenmile

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2025-02-03

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$112M

across 1 round

LATEST ROUND

Series C · $112M · 2025-02-03

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Tenmile: 1 round · Fireround

Company	Round	Amount	Announced	Role
AdvanCell AdvanCell is developing targeted alpha radiotherapies for cancer.	Series C Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$112M	2025-02-03	[ PART ]